Biotech: Will There Be Blood?

The health care sector has been a stellar performer since the outbreak of the financial crisis. The traditionally defensive sector held up better as stocks descended lower, and they have more than kept up the pace during the bull market over the last six years. A primary driver of this strong performance has been the biotech sector. But after an exceptionally strong run in recent years, it is worthwhile to consider whether this performance may have been a bit too good. In other words, is the biotech sector set up to bleed when the new bear market finally gets underway? And could it pull the health care sector down with it?

Please click on the link to read more of my article on Seeking Alpha.

Leave a Reply

Please log in using one of these methods to post your comment:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: